Active	Status	Sponsor type	Region	Phase	Filter
2 Active 1 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Zacher, Jeffrey
NCT06098079: Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)	Recruiting	4	8600	US	Naltrexone-Bupropion (NB) Combination, Placebo	Currax Pharmaceuticals	Obesity	01/29	07/29
NCT05817045: Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19	Completed	N/A	330	US	RD-X19, Sham	EmitBio Inc.	COVID-19	06/24	06/24